Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitoxantrone, Estramustine, and Vinorelbine vs Isotretinoin, Interferon Alfa, and Paclitaxel in Metastatic Hormone-Refractory Prostate Cancer
NCT00005847Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Apr 2001
- Primary completion
- Jul 2004
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of estramustine, mitoxantrone, vinorelbine, isotretinoin, interferon alfa in prostate cancer (PCa), sponsored by Eastern Cooperative Oncology Group. Started Apr 2001; status: completed.
02
Drugs
estramustinemitoxantronevinorelbineisotretinoininterferon alfa
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00005847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005847.